282 related articles for article (PubMed ID: 28110095)
1. Prophylaxis for Stress Ulcers With Proton Pump Inhibitors Is Not Associated With Increased Risk of Bloodstream Infections in the Intensive Care Unit.
Cohen ME; Hathway JM; Salmasian H; Liu J; Terry M; Abrams JA; Freedberg DE
Clin Gastroenterol Hepatol; 2017 Jul; 15(7):1030-1036.e1. PubMed ID: 28110095
[TBL] [Abstract][Full Text] [Related]
2. Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial.
; Young PJ; Bagshaw SM; Forbes AB; Nichol AD; Wright SE; Bailey M; Bellomo R; Beasley R; Brickell K; Eastwood GM; Gattas DJ; van Haren F; Litton E; Mackle DM; McArthur CJ; McGuinness SP; Mouncey PR; Navarra L; Opgenorth D; Pilcher D; Saxena MK; Webb SA; Wiley D; Rowan KM
JAMA; 2020 Feb; 323(7):616-626. PubMed ID: 31950977
[TBL] [Abstract][Full Text] [Related]
3. [Benefits and risks of stress ulcer prevention with proton pump inhibitors for critical patients: an observational cohort study with 1 972 patients].
Sun J; Wang B; Cao P; Zhu H; Lu K; Geng P; Tan D
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 May; 31(5):539-544. PubMed ID: 31198136
[TBL] [Abstract][Full Text] [Related]
4. Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.
Faleck DM; Salmasian H; Furuya EY; Larson EL; Abrams JA; Freedberg DE
Am J Gastroenterol; 2016 Nov; 111(11):1641-1648. PubMed ID: 27575714
[TBL] [Abstract][Full Text] [Related]
5. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea.
Buendgens L; Bruensing J; Matthes M; Dückers H; Luedde T; Trautwein C; Tacke F; Koch A
J Crit Care; 2014 Aug; 29(4):696.e11-5. PubMed ID: 24674763
[TBL] [Abstract][Full Text] [Related]
6. Peripherally inserted central venous catheter-associated bloodstream infections in hospitalized adult patients.
Ajenjo MC; Morley JC; Russo AJ; McMullen KM; Robinson C; Williams RC; Warren DK
Infect Control Hosp Epidemiol; 2011 Feb; 32(2):125-30. PubMed ID: 21460466
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.
Barletta JF; Sclar DA
Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023
[TBL] [Abstract][Full Text] [Related]
8. Incidence and cost of stress ulcer prophylaxis after discharge from the intensive care unit: a retrospective study.
Tan B; Norman R; Litton E; Heath C; Hawkins DJ; Krishnamurthy R; Sonawane R; Anstey MH
Crit Care Resusc; 2016 Dec; 18(4):270-274. PubMed ID: 27903209
[TBL] [Abstract][Full Text] [Related]
9. A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol.
Young PJ; Bagshaw SM; Forbes A; Nichol A; Wright SE; Bellomo R; Bailey MJ; Beasley RW; Eastwood GM; Festa M; Gattas D; van Haren F; Litton E; Mouncey PR; Navarra L; Pilcher D; Mackle DM; McArthur CJ; McGuinness SP; Saxena MK; Webb S; Rowan KM;
Crit Care Resusc; 2018 Sep; 20(3):182-189. PubMed ID: 30153780
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and Risk Factors for Inappropriate Continuation of Proton Pump Inhibitors After Discharge From the Intensive Care Unit.
Blackett JW; Faye AS; Phipps M; Li J; Lebwohl B; Freedberg DE
Mayo Clin Proc; 2021 Oct; 96(10):2550-2560. PubMed ID: 33308869
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness of Proton Pump Inhibitors vs Histamine Type 2 Receptor Blockers for Preventing Clinically Important Gastrointestinal Bleeding During Intensive Care: A Population-Based Study.
Lilly CM; Aljawadi M; Badawi O; Onukwugha E; Tom SE; Magder LS; Harris I
Chest; 2018 Sep; 154(3):557-566. PubMed ID: 29856970
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of ICU-Onset Bloodstream Infection: Prevalence, Pathogens, and Risk Factors Among 150,948 ICU Patients at 85 U.S. Hospitals.
Gouel-Cheron A; Swihart BJ; Warner S; Mathew L; Strich JR; Mancera A; Follmann D; Kadri SS
Crit Care Med; 2022 Dec; 50(12):1725-1736. PubMed ID: 36190259
[TBL] [Abstract][Full Text] [Related]
13. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR
Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413
[TBL] [Abstract][Full Text] [Related]
14. Early- and Late-Onset Bloodstream Infections in the Intensive Care Unit: A Retrospective 5-Year Study of Patients at a University Hospital in China.
Xie J; Li S; Xue M; Yang C; Huang Y; Chihade DB; Liu L; Yang Y; Qiu H
J Infect Dis; 2020 Mar; 221(Suppl 2):S184-S192. PubMed ID: 32176791
[TBL] [Abstract][Full Text] [Related]
15. Transfusion practice and blood stream infections in critically ill patients.
Shorr AF; Jackson WL; Kelly KM; Fu M; Kollef MH
Chest; 2005 May; 127(5):1722-8. PubMed ID: 15888852
[TBL] [Abstract][Full Text] [Related]
16. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007.
Burton DC; Edwards JR; Horan TC; Jernigan JA; Fridkin SK
JAMA; 2009 Feb; 301(7):727-36. PubMed ID: 19224749
[TBL] [Abstract][Full Text] [Related]
17. Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.
Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Møller MH;
Trials; 2016 Apr; 17(1):205. PubMed ID: 27093939
[TBL] [Abstract][Full Text] [Related]
18. Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality.
Prowle JR; Echeverri JE; Ligabo EV; Sherry N; Taori GC; Crozier TM; Hart GK; Korman TM; Mayall BC; Johnson PD; Bellomo R
Crit Care; 2011; 15(2):R100. PubMed ID: 21418635
[TBL] [Abstract][Full Text] [Related]
19. Histamine-2-receptor antagonist administration and gastrointestinal bleeding when used for stress ulcer prophylaxis in patients with severe sepsis or septic shock.
Barletta JF
Ann Pharmacother; 2014 Oct; 48(10):1276-81. PubMed ID: 24982312
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart review.
Shin S
Ther Clin Risk Manag; 2015; 11():649-57. PubMed ID: 26005351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
